CDC advisory panel recommends Pfizer boosters for adults 18-49 with underlying conditions

By a vote of 9-6, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices recommended boosters for those who have taken the Pfizer-BioNTech vaccine “based on individual benefit and risk who are 18-49 years with underlying medical conditions.”

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting